0 NYSE Companies - November 26, 2018Scorpio Bulkers Announces Time Charter-Out AgreementMONACO, Nov. 26, 2018 (GLOBE NEWSWIRE) — Scorpio Bulkers Inc. (NYSE:SALT) (“Scorpio Bulkers,” or the “Company”) announced today that it […]Read More
0 NYSE Companies - November 26, 2018Ocwen Financial Corporation Announces Senior Leadership AppointmentsTimothy Yanoti Named Executive Vice President and Chief Growth Officer Al Celini Appointed Senior Vice President, Chief Risk and Compliance […]Read More
0 TSX News - November 26, 2018Eldorado Gold Releases Updated Reserve and Resource StatementVANCOUVER, British Columbia , Nov. 26, 2018 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (“Eldorado” or “the Company”) today releases its […]Read More
0 NASDAQ Companies - November 26, 2018Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company-Merger would create publicly-traded immuno-oncology biotechnology company developing novel products for treating early- and late-stage cancer- -Growing product pipeline utilizing […]Read More
0 TSX Venture News - November 26, 2018THE FLOWR CORPORATION TO ANNOUNCE THIRD QUARTER 2018 FINANCIAL RESULTSMarkham, Ontario, Nov. 26, 2018 (GLOBE NEWSWIRE) — The Flowr Corporation (TSXV: FLWR) (“Flowr” or “the Company”), a Canadian Licensed […]Read More
0 NASDAQ Companies - November 26, 2018ELBIT IMAGING LTD. ANNOUNCES A NEW BUYBACK PLAN FOR ITS (SERIES I) NOTESTel Aviv, Israel, Nov. 26, 2018 (GLOBE NEWSWIRE) — Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ: EMITF) announced […]Read More
0 NASDAQ Companies - November 26, 2018Tasly and Mesoblast Initiate Development and Regulatory Activities for MPC-150-IM Heart Failure Cell Therapy in ChinaNEW YORK and MELBOURNE, Australia, Nov. 26, 2018 (GLOBE NEWSWIRE) — Tasly Pharmaceutical Group and Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced […]Read More
0 NASDAQ Companies - November 26, 2018Innovate Biopharmaceuticals Strengthens Clinical Development with the Addition of Patrick H. Griffin, M.D., F.A.C.P.RALEIGH, N.C., Nov. 26, 2018 (GLOBE NEWSWIRE) — Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical-stage biotechnology company focused on developing […]Read More
0 TSX Venture News - November 26, 2018ARHT Media Announces Upsizing of Private Placement Financing and Closing of First TrancheNOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) […]Read More
0 TSX Venture News - November 26, 2018Kraken Announces $0.5 Million Contract from Canadian Department of DefenseEarly Warrant Exercise Adds Cash to the Balance Sheet ST. JOHN’S, Newfoundland, Nov. 26, 2018 (GLOBE NEWSWIRE) — Kraken Robotics […]Read More